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 G-protein gated inwardly rectifying K+ (GIRK) channels are the major inwardly 
rectifying K+ currents in cardiac atrial myocytes and an important determinant of atrial 
electrophysiology. Inhibitory G-protein alpha subunits can both mediate activation via 
acetylcholine but can also supress basal currents in the absence of agonist. We studied this 
phenomenon using whole cell patch clamping in murine atria from mice with global genetic 
deletion of  Gi2, combined deletion of Gi1/Gi3 and littermate controls. We found that mice 
with deletion of Gi2 had increased basal and agonist activated currents particularly in the 
right atria whilst in contrast those with Gi1/Gi3 deletion had reduced currents. Mice with 
global genetic deletion of Gi2 had decreased action potential duration. Tissue preparations 
of the left atria studied with a multielectrode array from Gi2 knockout mice showed a 
shorter effective refractory period, with no change in conduction velocity, than littermate 
controls. Transcriptional studies revealed increased expression of GIRK channel subunit 
genes in Gi2 knockout mice. Thus different G-protein isoforms have differential effects on 
GIRK channel behaviour and paradoxically Gi2 acts to increase basal and agonist activated 
GIRK currents. Deletion of Gi2 is potentially proarrhythmic in the atria.  
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 Inwardly rectifying K+ channels are widely expressed in all chambers of the heart and 
are important in setting the resting membrane potential. However there is a dichotomy with 
the Kir2.0 family being predominant in the ventricles and His-Purkinje system and the Kir3.0 
family in atrial and nodal tissues (7; 18; 24; 45). The Kir3.0 channel family encodes G-
protein gated inwardly rectifying K+ channel present in neurons and neuroendocrine tissues 
in addition to the heart (11; 27). In the heart the channel is thought to consist largely of a 
heteromultimer of Kir3.1 and Kir3.4 (19). A characteristic of these channels is that they are 
activated by G-protein coupled receptors linked  to inhibitory G-proteins and specifically by 
the free G subunits (25; 42; 44). For example, in the sinoatrial node activation of the 
channel by acetylcholine released from the vagus nerve is responsible for heart rate slowing 
(39; 43).  Recently a study has shown a critical role for Kir3.4 in the kinetics of heart rate 
recovery to resting level after sympathetic activation (30).  
 Despite GIRK channel activation being mediated by G directly binding to domains 
on the channel, activation seems to occur largely via members of the inhibitory G-protein 
family (14; 21; 22; 35). In a series of studies from different laboratories using varied 
approaches a more complex model has emerged. It appears that the inhibiory G-protein 
heterotrimer is able to directly interact with channel and on activation heterotrimer 
dissociation occurs in a microdomain in or around the channel subunit. The dissoicated G 
subunit leads to activation (9; 21; 34; 38). However the G as either a monomer or as part of 
the heterotrimer may also play an important role leading to inhibition of channel activity and 
this process may be isoform dependent (5; 6; 15). Multiple isoforms of inhibitory G 
subunits (Gi1,  Gi2, Gi3 and, G) are present in atrial tissue, and their roles in modulating 
parasympathetic signal transduction remain unclear.  The subunits Gi2, Gi3 have been 
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shown to mediate signaling to GIRK in embryonic stem cell derived cardiomyocytes (Sowell 
et al., 1997). Our own work shows that Gi2 is important for heart rate regulation in-vivo (41; 
46) but this occurs via modulation in the SA node (not the atria) and might be via a 
mechanism independent of GIRK.   
 There is further complexity in that the right and left atria may be different and have 
gradients of channel expression (17). GIRK channels are expressed at higher levels in the 
right atrium in mice and humans. It has been proposed that the gradient of GIRK current, 
combined with the heterogenous distribution of parasympathetic innervation and adenosine 
receptor expression in the atria, may contribute to the ability of vagal nerve stimulation to 
augment dispersion of atrial refractoriness (12; 13; 23; 26; 40). The purpose of this study is to 
define the type of G-proteins involved in the signalling to GIRK in the atria, the possible role 





Material and Methods 
Gene-targeted mice 
 Mice with global deletion of Gi2, and Gαi1/Gαi3 (deletion of both Gαi1 and Gαi3) 
maintained on a Sv129 background were compared with wild-type littermate controls. The 
gene-targeting strategy, genotyping and confirmation of relevant Gαi/o deletions have 
previously been described (16; 46). Mice were maintained in an animal core facility under the 
UK Home Office guidelines relating to animal welfare. All procedures were approved by the 
local animal care and use committee and performed in accord with the UK Home Office 
regulations (PPL 70\7665). All mice were kept in a temperature controlled environment (21-
24°C) with 12/12hr light/dark cycle. Animals were allowed ad-libitum access to standard 
rodent chow and drinking water. Mice aged 3–4 months were used for this study. Littermate 
controls were obtained from the Gi2 crosses.  
 
Quantitative real time reverse transcriptionPCR 
 RNA was isolated from the left atria and right atria from mice with global deletion of 
Gi2, maintained on a Sv129 background and, wild-type littermate controls using the RNeasy 
kit (Qiagen). Briefly, hearts were removed from each group of mice (Gi2 (+/+) and, Gi2( -/-
)), washed with cold PBS, left atria and right atria were isolated and immediately placed in 
RNA Later. RNA was extracted using RNeasy kit (cat no. 74104 Qiagen). cDNA was 
synthesized using the High capacity cDNA reverse transcription Kit (4368814  Life 
technologies) quantified and 50ng of cDNA/20μl was used for the subsequent real time 
expression assay. Real-time PCR was performed using Taqman gene expression Assays (Life 
technologies). All genes (Mm00434618_m1: Kcnj3, Mm01175829_m1: Kcnj5, 
Mm00492379_m1: Gnai3, Mm01165301_m1: Gnai1, Mm00494677_m1: Gnb1, 
6 
 
Mm00501973_m1: Gnb4, Mm01165191_m1: Gng11, Mm00515876_m1: Gng7) were 
assayed in triplicates and GAPDH was used as the house keeping gene.   
 
Single-cell isolation and electrophysiology 
 Atrial and sinoatrial cells were isolated using an adapted method for isolation of 
sinoatrial cardiomyocytes (29).  Briefly, mice were injected with heparin and beating hearts 
were removed under pentobarbital (3 ml/kg) and ketamine (1 ml/kg) anaesthesia. The left and 
right atria were excised in normal Tyrode solution containing (mM): NaCl, 140; KCl, 5.4; 
CaCl2, 1.8; MgCl2, 1; Hepes–NaOH, 5; and D-glucose, 5.5; (pH 7.4). Strips of tissues were 
enzymatically digested in a low-Ca2+ and low- Mg2+ solution containing (mM): NaCl, 140; 
KCl, 5.4; MgCl2, 0.5; CaCl2, 0.2; KH2PO4, 1.2; taurine, 50; D-glucose, 5.5; Hepes–NaOH, 5; 
pH 6.9. Collagenase type II (224 U/ml, Worthington), elastase (1.9 U/ml, Worthington), 
protease (0.9 U/ml, Sigma Aldrich), and bovine serum albumin (BSA) 1 mg/ml were added. 
The digestion step was carried out for 20 min or 45 min, for atrial and SAN tissue, 
respectively, under gentle mechanical agitation at 37°C. Tissue strips were then washed out, 
and transferred into a modified ‘Kraftbrühe’ (KB) medium  containing (mM): l-glutamic 
acid, 70; KCl, 20; KOH, 80; d-β-OH-butyric acid, 10; KH2PO4, 10; taurine, 10; BSA, 1 
mg/ml; and Hepes–KOH, 10; pH 7.4. Single myocytes were manually dissociated in KB 
solution by employing a fire-polished glass pipette. Finally, extracellular Ca2+ concentration 
was recovered up to 1.3 mM. A drop of cell suspension was seeded onto sterilised laminin-
coated coverslips. After 30-45 min, Tyrode solution containing 10% BSA was added, and 
cells were stored at 37°C until used in humidified 5% CO2-95% air at 37
0C. All experiments 
were performed at room temperature. 
 Patch-clamp current recordings were performed with an Axopatch 200B amplifier 
(Axon Instruments) using fire-polished pipettes with a resistance of 3-4 M pulled from 
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filamented borosilicated glass capillaries (Harvard Apparatus, 1.5 mm OD x 1.17 mm ID). 
Data were acquired and analysed by using a Digidata 1322A interface (Axon Instruments) 
and pCLAMP software (version 10, Axon Instruments). Action potentials were recorded in 
the current clamp mode. Cardiomyocytes were stimulated using a 5 ms current pulse. The 
resting membrane potential, the magnitude of the initial depolarisation and the action 
potential duration at which 50 and 90% repolarisation occurred were measured (APD50 and 
APD90 respectively). The cells were clamped at -60 mV in an extracellular solution 
containing (mM): NaCl 135, KCl 5.4, CaCl2 2, MgCl2 1, NaH2PO4 0.33, H-HEPES 5, 
Glucose 10 (buffered to pH 7.4 with NaOH). The intracellular solution was (mM): K 
gluconate 110, KCl 20, NaCl 10, MgCl2 1, MgATP 2, EGTA 2, Na2GTP 0.3 (buffered to pH 
7.2 with KOH). The liquid junction potential was +13 mV. 
 
Measurement of atrial electrophysiology using multielectrode arrays 
 Using a multi-electrode array (MEA, Multichannel Systems), we investigated the 
effect of ablation of Gi2 on electrophysiological parameters in ex-vivo atrial tissue (33). Left 
atria were dissected from isolated mouse hearts after mounting in a Langendorff setup and 
perfused with Krebs solution supplemented with 30 mM 2, 3-butanedione monoxime. The 
tissue was then transferred to the array perfused with Krebs solution (37°C; 95% O2 / 5% 
CO2). Experiments were conducted in the absence and the presence of 10 nM – 10 µM 
carbachol. Left atrial electrophysiology was assessed during electrical stimulation using a 
multi-electrode array (MEA) system which allows non-invasive synchronous multifocal 
recording of extracellular field potentials. The MEA (MEA2100, Multichannel Systems, 
Reutlingen, Germany) consists of 60 microelectrodes arranged in an 8×8 matrix, with a 20 
μm electrode diameter and an inter-electrode distance of 200 μm, Myocardial samples were 
positioned in the center of the MEA dish, held in contact with electrodes by a holder, and 
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continuously superfused with oxygenated  Krebs solution at 37°C. Baseline electrical 
stimulation (bipolar pulses, 2x threshold, 2ms duration, 4 Hz frequency) was applied via one 
of the MEA microelectrodes. Field potential data were acquired simultaneously from all 60 
microelectrodes. S1-S2 train stimulation with a S1-S1 cycle length of 250 ms was used to 
assess atrial effective refractory period (AERP). To assess conduction properties, isolated 
atria were sequentially stimulated (4 Hz) from one electrode of each 4 edges of the array. 
Field potential recordings obtained in these conditions were processed using LabChart7 
(ADINSTRUMENTS, UK) to define local activation time based on minimum of the 
derivative of field potential. Average conduction velocity (CV) was calculated by linear 
regression relating inter electrode distance to activation times, as previously described (Opel 
et al., 2015). The slope of the regression line was the average conduction velocity (CV). 




The mean and standard error of the mean are presented. Student’s t-test or one way 






Inward currents in right and left atria  
 Using a step voltage protocol, current-voltage (I-V) relationships of atrial 
cardiomyocytes  isolated from the right atria (RA) and left atria (LA) were compared  in 
control mice (normal genotype littermates from the Gi2 crosses) (Figure 1). Currents were 
larger and showed greater inward rectification in RA than in the LA in the presence of 
carbachol (Figure 1 and 3). Experiments were also performed in the presence of GTPSin the 
patch pipette to activate GIRK currents in the absence of receptor stimuation. In these 
experimental conditions,  we still obtained a larger current in RA (-59.8 ± 6.5 pA/pF, n=5) 
compared to LA (-27.8 ± 2 pA/pF, n=5) of Gi2 (+/+) atrial myocytes . 
 In Gi2 (-/-) mice, the I/V relationship of the RA was altered with larger basal and 
carbachol-activated inward currents in  the RA (Figure 2 and 4). In mice with the combined 
deletion of Gi1/Gi3 there were reduced carbachol-activated currents in the RA (Figure 3 
and 4). The effects of Gi2 deletion were more pronounced in the RA, leading to loss of 
regional difference across the atria. Kinetics of GIRK current activation by carbachol were 
assesed using a twenty second application of agonist as we have previously described (2; 3; 
31). There were no major changes in activation and rapid desensitisation between RA and LA 
and in the mice with either Gi2 or Gi1/Gi3 deletion (Table 1). In contrast, deactivation was 
slower in the RA than the LA but this pattern was not changed  in the Gi2 (-/-) mice and in 
mice with combined Gi1/Gi3 deletion (Table 1).  
 We examined for expression changes of relevant components in the signalling 
cascade in the RA and LA of Gi2 (-/-) mice and littermate controls. Using quantitative real 
time reverse transcription PCR, we measured the expression of Gi1 (Gnai1), Gi3 (Gnai3), 
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some representative Gs (Gnb1, Gnb4, Gng7, Gng11) and the GIRK chanel subunits (Kcnj3 
and Kcnj5) and the results are shown in Table 2. Gnb4 and Gng11 were chosen as they have 
potentially been associated with cardiovascular traits in particular heart rate in genome wide 
association studies (10). In general, the changes between  Gi2 (-/-) mice and littermate 
controls are modest even when significant. However in Gi2 (-/-) mice GIRK channel subunit 
kcnj5 expression was increased in both atrial chambers suggesting that some of the 
differences in regulation of GIRK channels in Gi2 (-/-) mice may be related to 
transcriptional changes in channel expression.  
 
Comparison with the SA node 
 We also isolated and patch clamped SA nodal cells. GIRK currents were of a similar 
magnitude as that in the RA but rectified more strongly and deactivated more rapidly after 
carbachol application  (Figure 5 and Table 1). The properties of the currents in the SA node 
were unaffected in mice with global genetic deletion of Gi2 or Gi1/Gi3. 
 
Single-cell action potentials  
 It might be predicted that an increased GIRK current in Gi2 (-/-) mice might lead to a 
shortened action potential duration and atrial effective refractory period. We compared atrial 
action potentials in the RA and LA myocytes in control and Gi2 (-/-) mice and, found that 
RA atrial myocytes from RA  Gi2 (-/-) mice had a shorter APD90 than control RA myocytes. 
A similar trend was observed in the LA myocytes though this was not statisitically significant 
(Figure 6).  
 Carbachol (10µM) led to shortening of APD with a more pronounced effect in the 
RA. The decrease of the APD90 reached 61 ± 3 % in Gi2 (+/+) LA (n=9) and 76 ± 3 % in 
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Gi2 (+/+) RA (n= 8, p=0.006). In Gi2 (-/-) murine atrial myocytes, carbachol decreased 
APD90 by 57 ± 7% in the LA (n=7) and by 50 ± 8% in the RA (n=7, NS).  
 
Tissue electrophysiology 
 We performed an analysis of the tissue electrophysiology in isolated left atria using a 
multielectrode array. The analysis of intact right atria was complicated by the intrinsic 
pacemaking activity. In the Gi2 (-/-) LA, there was a shortened effective refractory period 
(ERP), and no alteration in conduction velocity in comparison to Gi2 (+/+) LA, resulting in 
a significant decrease in potential path length for re-entry (Figure 7). A similar relative 
decrease of left atrial ERP was observed in the presence of carbachol (10 nM to 10 µM) 
between Gi2 (-/-) and control, with no significant difference in log EC50, i.e. -6.9 +/- 0.4 vs -







Our main findings are that in murine atria specific isoforms of inhibitory G-proteins 
have defined roles in controlling GIRK channel function. Specifically Gi2 suppresses the 
basal and agonist induced activity of GIRK whilst Gi1 and\or Gi3 mediate muscarinic 
activation of the current. Our experiments are in agreement with previous work, showing 
larger GIRK currents in the RA and the SAN regions compared to the LA region (12; 13; 23; 
26; 40). Deletion of Gi2 accentuated this chamber asymmetry whilst it was attenuated in 
mice with global genetic deletion of Gi1 and Gi3. In keeping with the changes in GIRK 
currents, the global genetic deletion of Gi2 resulted in a shortened action potential duration, 
reduced tissue atrial effective refractory period and reduced minimum wave front cycle 
length.    
These findings complement our previous work in which we have investigated heart 
rate regulation in various G-protein alpha subunit knockout mice (41; 46). Specifically mice 
with global and SA node specific deletion of Gi2 were tachycardic with impaired high 
frequency responses in heart rate variability studies. It is worth stating that the majority of 
studies reported here were conducted in the atria and reveal differences between the SA node 
and across the atria in GIRK channel signalling and G-protein dependency. Our observations 
reported here in the SA node show preserved signalling via muscarinic receptors to GIRK 
channels with deletion of both Gi2 and combined Gi1\Gi3. This suggests that GIRK 
channel independent mechanisms may be important in determining the in-vivo phenotype in 
Gi2 knockout mice. Specifically the loss of negative coupling to adenylate cyclase, fall in 
cAMP and effects on the hyperpolarization activated cyclic nucleotide gated channel and\or 




Inhibitory G-protein  subunits and GIRK channel function 
 GIRK channels are traditionally viewed as an example of a canonical effector 
activated by G subunits. However it is clear that Gsubunits play a role. For example, we 
demonstrated in heterologous systems that channel activation seemed to be preferentially 
activated via inhibitory rather than stimulatory G-proteins (21). Furthermore, studies have 
shown that the inhibitory G-protein heterotrimer can bind to the channel complex (6; 9; 37). 
This interaction may have important functional consequences namely that it surpresses basal 
current activity (6; 34). In other studies the Dascal laboratory demonstrated that there may be 
isoform differences in the nature of this behaviour between Gi1 and Gi3 (15). One issue 
with a proportion of this work is that the conclusions often depend on overexpression of 
engineered components in heterologous expression systems. It is unclear whether these kinds 
of effect occur in native settings with physiological levels of G-protein and channel 
expression. In this study in native atrial myocytes we show that deletion of Gi2 leads to an 
unexpected increase in basal and agonist activated currents. One interpretation of this finding 
is that inhibitory G-protein  subunits do indeed have an ability in-vivo to negatively regulate 
GIRK currents. However, our data reveal another potential mechanism namely transcriptional 
changes in GIRK channel subunit expression engendered by Gi2 deletion. Specifically in the  
Gi2 (-/-) mice, expression levels for kcnj3 and kcnj5 mRNA, in a statistically significant 
fashion for the latter,  were increased compared to littermate controls and the magnitude of 
these effects were comparable to the changes in GIRK current density observed. In contrast, 
combined deletion of Gi1 and Gi3 impairs the magnitude of muscarinic activation 
sugessting that one of  Gi1 and Gi3 or both is important for mediating the agonist induced 
response. Although we studied single isolated cardiac cells ex-vivo, it is still possible that 
extracardiac effects could lead to long lasting changes in myocyte biology.  
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 We also examined if deletion of Gi2 had effects on the expression of other 
components in the signalling cascade namely Gnai1, Gnai3, Gnb1, Gnb4, Gng7 and Gng11. 
These experiments have substantial practical complications as there are five G-protein beta 
genes and fourteen G-protein gamma genes. We selected four to examine for compensatory 
changes in part determined from genome wide association studies in heart rate and our own 
unpublished studies (10). Whilst there were some changes these were modest in magnitude 
(possible decreases in expression of gnb1 and gng11 in the LA but no significant change 
change in gnb4, gng7, gnai1 or gnai3). Furthermore, in the functional studies in Gi2 (-/-) 
mice, carbachol led to increased agonist induced current activation suggesting G expression 
was not limiting for signal transduction.    
 
Regional differences   
 There were regional differences in the nature and coupling profile of GIRK currents 
in supraventricular tissues. GIRK currents were larger in the right atrium and SA node and 
these differences were accentuated in the right atrium by global genetic deletion of Gi2. 
Kinetic analysis also showed that GIRK current inactivation is faster in the RA and the SAN 
regions compared to the left atrium. This fast inactivation of the GIRK currents in the RA and 
pacemaker regions could reflect differential expression of regulators of G-protein signalling 
that can increase the hydrolysis rate of GTP bound and active G-protein  subunits (4; 33; 
36). Furthermore, GIRK currents were more outwardly rectifying in the SA node and this 
could contribute to their importance in recovery of heart rate after exercise as explored 
recently in GIRK4 knockout mice as they may play a more significant role at depolarised 
potentials (30).  
 Another interesting finding is that the molecular details of the signalling system differ 
between closely related regions of the heart. So whilst Gi2 and Gi1\Gi3 seem to have roles 
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in inhibition and activation respectively in the atria this pattern does not exist in the SA node. 
Indeed, a significant amount of redundancy is suggested as GIRK channel activation was 
little affected in both Gi2 and Gi1\Gi3 knockout mice. This suggests that the specifics of 
the signalling can be tissue and region dependent. G-protein deletion had no effect on the 
kinetics of signalling suggesting that this was predominantly determined by other factors such 
as the expression of regulators of G-protein signalling.  
 
G-protein deletion and predisposition to arrhythmia 
  The increase in GIRK currents in mice with global genetic deletion of Gi2 might 
lead to more general effects on single cell and tissue level electrophysiology. Indeed, the 
increase GIRK currents was sufficient to decrease the action potential duration. Furthermore, 
in whole left atrial preparations, Gi2 shortened the atrial effective refractory period without 
an effect on conduction velocity leading to a decrease minimum wave front cycle length. This 
change would be potentially proarrhythmic. We have also previously observed that Gi2 
deletion in the ventricle and silencing of the vagal input increases the predisposition to 
ventricular arrhythmia (28; 47). The mechanism is different with an effect on calcium 
channel regulation and expression (47). It is also known that GIRK4 knockout mice are 
resistant to the induction of atrial fibrillation whilst RGS6 knockout mice with increased 
GIRK channel activity are predisposed (18; 36). Other investigators have observed in the dog 
that Gi2 and\or Gi3 knockdown using cell permeable peptides may surpress vagally 
mediated atrial fibrillation when delivered into the posterior left atrium (1). The authors did 
not examine the specifics of the mechanism and whether it was related to GIRK channel 
activation.  
 Action potential duration has been shown to decrease with increasing distance from 
the SAN region (26; 32). In contrast, GIRK currents are larger in the right atrium than left 
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atrium and this suggests there are other important electrophysiological determinants of the 
variation in action potential duration across the atria. The shortened action potential duration 
in the left atrium is potentially important as it may allow the support of higher frequency 
rotors in and around the pulmonary veins (40) though in this study the authors found higher 
GIRK currents in the left versus right atrium of sheep. Despite this lack of consensus, 
suppression of GIRK channel activity in the left atrium abrogates re-entry and atrial 
fibrillation (8).   
 
Conclusions 
 Whilst not directly addressing the issue our studies are compatible with the long 
standing view that Gsubunits are important for GIRK channel activation. However they do 
reveal layers of complexity in how the Gheterotrimeric G-protein subunit might shape this 
response. A body of work, which we discuss above, has suggested various ways by which 
this might occur including direct protein-protein interaction between G-protein heterotrimer 
components and channels domains. However much of this work is accomplished by 
expressing components, often at non-physiological levels, in model cell systems. Here we 
examine native signalling in various chambers and regions of the heart using mice with 
global genetic deletion of Gsubunits. Our overall conclusion is that there is much plasticity 
in the system with the exact importance of a specific G subunit being dependent on tissue 
region expression. G subunits may directly suppress GIRK currents in native systems but 
this could be accounted for by additional effects on channel transcription. These observed 
phenomena may result from variations in G subunit expression or compartmentation with 
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Table 1. Deletion of Gi2 or Gi1/3 and GIRK currents kinetics across the atria. 
Cells were clamped at -60 mV and carbachol was applied for 20 ms with a fast perfusion 
system. Characteristics of the GIRK currents kinetics are presented in the table for the LA, 
RA and SAN region for the Gi2 (+/+), Gi2 (-/-), and Gi1/3 (-/-). The current inactivation 
characteristics (τdeac and lag inac) were faster in the RA and San compared to the LA 
(*p<0.05). 
 
Table 2. Quantitative real-time reverse transcription PCR to measure gene 
expression in the RA and LA. Quantitative real-time reverse transcription PCR was 
performed as described in the Materials and Methods for the genes indicated in the Table. 
Measurements were performed in triplicate from Gi2 (-/-) mice (n=3) and littermate controls 






Figure 1. GIRK currents in the atrial tissue. A. Representative traces of currents 
measured in atrial myocytes isolated from the left and right atria of Gi2 (+/+) mice. B. Mean 
current-voltage relationships. Atrial myocytes were challenged with 10 M carbachol. GIRK 
currents were larger in RA compared to LA. 
 
Figure 2. Deletion of Gi2 affect the gradient of GIRK across the atria. 
Representative traces and mean current-voltage relationships of currents measured in atrial 
myocytes isolated from the left and right atria of Gi2 (-/-) mice. Basal GIRK currents were 
larger in RA compared to Gi2 (+/+). 
 
 Figure 3. Deletion of Gi1/3 affect the gradient of GIRK across the atria. 
Representative traces and mean current-voltage relationships of currents measured in atrial 
myocytes isolated from the left and right atria of Gi1/3 (-/-) mice. There was a loss of GIRK 
current gradient between the LA and RA. 
 
Figure 4. Comparison of GIRK currents in the LA and RA. Bar graph showing 
maximum GIRK currents measured at -120 mV. In Gi2 (+/+), carbachol (10 M) led to a 
larger activation of GIRK currents in the RA. Deletion of Gi2 led to larger basal and 
carbachol-activated currents in the RA. Deletion of Gi1/3 led to smaller carbachol-activated 
currents in both LA and RA with a marked effect in the RA, thee consequence being a loss of 




Figure 5. GIRK current in the SAN. Left panel: Representative traces of GIRK 
currents in control and after activation with 10 M carbachol. Comparison is made between 
Gi2 (+/+), Gi2 (-/-) and Gi1/3 (-/-). Right panel: Mean current-voltage relationships. Atrial 
myocytes were challenged with 10 M carbachol. GIRK currents were not affected by Gi 
deletion. 
 
Figure 6. Consequence of the deletion of Gi2 on the action potential of single 
cardiomyocytes. Single cardiomyocytes AP were measured after stimulation of cells by a 5 
ms pulse after pacing at 1Hz for 60 seconds. The APD90 were longer in the RA, although the 
mean values did not reach significance when analyses with t-test due to the variability of the 
data values. Both APD50 and APD90 were significantly reduced in the Gi2 (-/-) right atria 
(* p<0.05). 
 
Figure 7. Electrophysiology of isolated right and left atria. A) Atrial effective 
refractory period (ERP), (B) conduction velocity (CV) and (C) minimum wave front cycle 
length (mWFCL) in left atrial tissue deficient in Gi2 (-/-) mice compared to Gi2 (+/+) (* p-
value <0.05). Dose-response for carbachol on left atrial AERP (D), relative AERP to baseline 































Lag + TTP, s 1.06 ± 0.06 0.84± 0.05 0.99 ± 0.01 0.9 ± 0.05 0.82 ± 0.04 0.96 ± 0.05 1 ± 0.05 0.68 ± 0.04 0.79 ± 0.07
tac , ms 188 ± 11.1 142 ± 11.3 162 ± 24.4 156 ± 10.8 153 ± 27 144 ± 7.2 256 ± 45 114 ± 13 143 ± 13.7
tdeac, ms 2996 ± 458 811 ± 66.6 607 ± 92 2654 ± 438 779± 137 466 ± 40.3 3567 ± 739 824 ± 141 493 ± 71.3
lag inac, s






























WT KO WT KO
Genes LA LA RA RA
ΔCT  ΔCT  ΔCT  ΔCT 
Gnai1 6.75 ± 0.06 6.98 ± 0.05 8.46 ± 0.35 8.15 ± 0.09
Gnai3 6.90 ± 0.18 6.65 ± 0.08 6.98 ± 0.12 7.42± 0.09
Gnb1 4.76 ± 0.14 5.72 ± 0.25* 5.21 ± 0.50 5.50 ± 0.07
Gnb4 7.98 ± 0.18 7.72 ± 0.07 8.75 ± 0.18 8.60 ± 0.08
Gng7 10.8 ± 0.14 11.5 ± 0.14 11.5 ± 0.51 11.7 ± 0.16
Gng11 7.04 ± 0.11 7.49 ± 0.03* 7.56 ± 0.21 7.43 ± 0.04
Kcnj3 2.86 ± 0.14 2.30 ± 0.07 3.62 ± 0.18 3.00 ± 0.05
Kcnj5 5.38 ± 0.12 4.86 ± 0.06* 5.51 ± 0.24 4.94 ± 0.07*
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